Specialty

Melanotan 2 UAE: Melanocortin Research Peptide Guide — What It Is and Where to Buy (2026)

· · 5 min read
Melanotan 2 MT-2 melanocortin research peptide UAE Dubai
!
💡What You’ll Learn
  • Key Facts at a Glance
  • What Is Melanotan 2?
  • How Does Melanotan 2 Work?
  • Melanotan 2 Research: Key Areas
  • Melanotan 2 vs PT-141
🔄 Last updated: May 12, 2026
5 min read|1,037 words

Melanotan 2 (MT-2) is one of the most extensively researched melanocortin receptor agonists available. Originally developed at the University of Arizona as part of a pigmentation research programme, Melanotan 2 has since been studied across a broad range of applications — from skin pigmentation and photoprotection to sexual function and appetite regulation — making it one of the most multi-functional research peptides in the field.

02

What Is Melanotan 2?

Melanotan 2 is a synthetic analogue of alpha-melanocyte stimulating hormone (α-MSH) — a naturally occurring peptide derived from the proopiomelanocortin (POMC) protein. The amino acid sequence of MT-2 is a cyclic heptapeptide: Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂. The cyclic structure and D-Phe substitution confer significantly greater potency and metabolic stability compared to native α-MSH.

MT-2 was developed in the early 1990s by researchers at the University of Arizona Cancer Center, initially with the goal of creating a “tanning agent” that could protect fair-skinned individuals from UV-induced skin damage. Research rapidly expanded to reveal a much broader pharmacological profile through its agonism of melanocortin receptors MC1R through MC5R.

03 · Work

How Does Melanotan 2 Work?

📬
Stay Updated on Peptide Research

Latest research insights. No spam, ever.

TL;DR. MT-2 is a non-selective melanocortin receptor agonist — it activates MC1R (pigmentation), MC3R/MC4R (appetite, sexual function), and MC5R. The lack of selectivity is exactly what makes it a multi-application research compound.

MT-2 exerts its effects by binding to and activating melanocortin receptors (MCRs). Different receptor subtypes mediate different physiological effects:

Item 01

MC1R (skin):

Stimulates melanogenesis — production of melanin in melanocytes — producing a tanning effect independent of UV exposure

Item 02

MC3R and MC4R (brain/hypothalamus):

Regulate energy homeostasis, appetite suppression, and sexual arousal pathways

Item 03

MC4R (CNS):

The primary receptor mediating MT-2’s effects on sexual function — activates pro-erectile pathways in the brain and spinal cord

Item 04

MC5R (exocrine glands):

Regulates sebaceous and exocrine gland secretion

04 · Research

Melanotan 2 Research: Key Areas

TL;DR. Three major published research areas: skin pigmentation and photoprotection (MC1R), sexual function (MC4R — the PT-141 connection), appetite and energy balance (MC3R/MC4R). MT-2 is the parent compound; PT-141 is the more selective metabolite.

Skin Pigmentation and Photoprotection

The original application of MT-2 research was photoprotection. University of Arizona clinical trials demonstrated that MT-2 produced significant skin darkening in fair-skinned volunteers, with effects persisting for weeks after the last administration. The hypothesis was that increased melanin would provide natural photoprotection against UV-induced DNA damage and skin cancer risk.

Sexual Function Research

Perhaps the most surprising finding in MT-2 research was its potent pro-erectile effects, discovered serendipitously in early human trials. Subsequent research confirmed MC4R activation in the hypothalamus and spinal cord as the mechanism — triggering central pro-erectile signalling independent of peripheral vascular mechanisms. This led to the development of PT-141 (Bremelanotide), a derivative now FDA-approved for hypoactive sexual desire disorder.

Appetite and Energy Balance

MC3R and MC4R activation in the hypothalamus suppresses appetite and increases energy expenditure. Research in obese animal models has shown significant reductions in food intake and body weight with MT-2 administration — an area of ongoing investigation given the growing interest in melanocortin pathways for metabolic disease.

05 · PT-141

Melanotan 2 vs PT-141

CompoundStructureMC1R (pigmentation)MC4R (sexual function)Status
Melanotan 2Cyclic heptapeptideStrong agonistStrong agonistResearch only
PT-141 (Bremelanotide)MT-2 metaboliteMinimalStrong agonistFDA-approved (Vyleesi)
α-MSH (native)Linear 13-aa peptideModerate agonistWeak agonistEndogenous

06 · Research

Research Dosing Protocol (Reference)

Research use only. Loading phase 0.25–0.5 mg daily for 1–2 weeks; maintenance 0.5–1 mg weekly. Slow titration is standard to manage GI side effects (nausea) and flushing common with MT-2.

For research reference only. Not approved for human use.

In clinical research, MT-2 has been administered via subcutaneous injection at doses ranging from 0.025mg/kg to 0.1mg/kg. Emirates Peptides supplies Melanotan 2 in 10mg vials. Reconstitute with bacteriostatic water.

Storage

Item 01

Lyophilised:

Store at 2-8°C, protect from light

Item 02

Reconstituted:

2-8°C, use within 28 days

07

Where to Buy Melanotan 2 in the UAE

  • ✅ COA-verified, ≥99% purity
  • ✅ 10mg vials
  • ✅ Fast delivery to Dubai, Abu Dhabi and all UAE emirates
  • ✅ GCC shipping available
  • ✅ Cash on delivery in Dubai

Order Melanotan 2 in UAE →

08 · Questions

Frequently Asked Questions

Is Melanotan 2 the same as PT-141?

No. PT-141 (Bremelanotide) is a metabolite of Melanotan 2 that’s been refined to be more selective for sexual function endpoints (MC4R). MT-2 is the parent compound with non-selective melanocortin receptor activity covering pigmentation, appetite, and sexual function research.

What is the typical Melanotan 2 research dose?

A loading phase of 0.25–0.5 mg daily for 1–2 weeks, followed by maintenance at 0.5–1 mg weekly. Slow titration is standard to manage common side effects like nausea and flushing.

What are the common side effects in MT-2 research models?

The most commonly reported side effects in research are nausea (especially in the first 1–2 weeks), flushing, transient appetite suppression, and increased libido. These typically attenuate after the loading phase ends. Slow titration is the standard mitigation.

Does Melanotan 2 cause skin darkening immediately?

No. MT-2 stimulates melanin synthesis via MC1R activation, but visible pigmentation requires concurrent UV exposure to drive the melanogenesis process. Research subjects without UV exposure show minimal pigmentation change despite full MT-2 dosing.

How does MT-2 relate to appetite regulation?

MT-2 activates MC3R and MC4R — the central melanocortin receptors that signal satiety in the hypothalamus. This is why temporary appetite suppression is one of the consistent observations in MT-2 research, particularly during the loading phase.

Melanotan 2 is supplied strictly for laboratory research use and is not a controlled substance in the UAE. Note that MT-2 is not approved for human therapeutic use in any jurisdiction worldwide.

Disclaimer: For laboratory research use only. Not approved for human use. Not medical advice.

Was this article helpful?

Emirates Peptides Research Team

Emirates Peptides Research Team curates evidence-based content on peptide science for research professionals across the UAE and beyond.

Share this article

Emirates Peptides Research Team

Scientific Content

Our research team curates evidence-based content on peptide science, ensuring all articles are grounded in peer-reviewed literature and current scientific understanding. All products are for laboratory research use only.

Explore Research-Grade Peptides

HPLC-verified, lab-tested peptides for your scientific research. Fast delivery across the UAE.

Browse All Peptides

Selected Research References

Selected scientific references for research context only. Products remain for laboratory research use and are not for human use.

  1. Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study (PMID: 8637402; DOI: 10.1016/0024-3205(96)00160-9)
  2. Preformulation studies with melanotan-II (PMID: 7983590; DOI: 10.1002/jps.2600830805)
  3. Alpha-melanocyte-stimulating hormone and related tripeptides (PMID: 18612139; DOI: 10.1210/er.2007-0027)
  4. Therapeutic peptides: current applications and future directions (PMID: 35165272; DOI: 10.1038/s41392-022-00904-4)
Reviewer
Medical Reviewer

Emirates Peptides Research Team

A dedicated coalition of biochemists and clinical researchers focusing on advanced peptide synthesis and pharmacological applications. All data is verified against current clinical trials.